Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: A comparative study;Efectos de la Diabetes Inducida por STZ en los Pesos Relativos de Riñón, Hígado y Páncreas en Ratas Albinas: Un Estudio Comparativo

International Journal of Morphology

Volumn 28, Issue 1, 2010, Pages 135-142

  Zafar, Muhammad ^a   Naeem ul Hassan Naqvi, Syed ^b  

^a BAQAI MEDICAL UNIVERSITY   (Pakistan)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Body weights; Liver; Pancreas; Rats; Stz diabetes; Weight of kidney

Indexed keywords

EID: 77954180564     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022010000100019     Document Type: Article

References (34)

1. Ahmed, I.; Adeghate, E.; Sharma, A. K.; Pallot, D. J. & Singh, J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocindiabetic rat. Diabetes Res. Clin. Pract., 40(3):145-51, 1998.
2. Bennett, R. A. & Pegg, A. E. Alkylation of DNA in rat tissues following administration of Streptozotocin. Can. Res., 41:2786-90, 1981.
3. Dorr, R. T. & Fritz, W. L. Cancer chemotherapy. Hand book. London, Kinapton, 1980. pp.632-37.
4. Fadillioglu, E.; Kurcer, Z.; Parlakpinar, H.; Iraz, M. & Gursul, C. Melatonin treatment against remote open injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch. Pharm. Res., 31(6):705-12, 2008.
5. Flyvbjerg, A.; Landau, D.; Domene, H.; Hernandez, L.; Gronback, H. & Le Roith, D. The role of growth hormone, insulin-like growth factors (IGFs), and IGF binding proteins in experimental diabetic kidney disease. Metabolism, 44(10):67-71, 1995.
6. Gu, D.; Arnush, M. & Sarvetnic, N. Endocrine/exocrine intermediate cells in Streptozotocin treated Ins-IFNgamma transgenic mice. Pancreas, 15(3):246-50, 1997.
7. Habibuddin, M.; Daghriri, H. A.; Humaira, T.; Al-Qahtani, M. S. & Hefzi, A. A. Antidiabetic effect of alcoholic extract of Caralluma sinaica L. on streptozotocin-induced diabetic rabbits. J. Ethnopharmacol., 117(2):215-20, 2008.
8. Han, K.; Zhou, H. & Pfeifer, U. Inhibition and restimulation by insulin of cellular autophagy in distal tubular cells of the kidney in early diabetic rats. Kidney Blood Press. Res., 20(4):258-63, 1997.
9. Heidari, Z.; Mahmoudzadeh-Sagheb, H. & Moudi, B. A quantitative study of sodium tungstate protective effect on pancreatic beta cells in streptozotocin-induced diabetic rats. Micron., 39(8):1300-5, 2008.
10. Ichinose, K.; Maeshima, Y.; Yamamoto, Y.; Kinomura, M.; Hirokoshi, K.; Kitayama, H.; Takazawa, Y.; Sugiyama, H.; Yamasaki, Y.; Agata, N. & Makino, H. 2-(8-hydroxy- 6-methoxy-1-oxo-1h-2 benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type-2 diabetic mice. Diabetes, 55(5):1232-42, 2006.
11. Jacobs, M. L.; Chandrasekhar, V.; Bartke, A. & Weber, R. F. Early effects of streptozotocin induced diabetes on insulin-like growth factor-1 in the kidneys of growth hormone-transgenic and growth hormone-deficient dwarf mice. Exp. Nephrol., 5(4):337-44, 1997.
12. Kang, N.; Alexander, G.; Park, J. K.; Maasch, C.; Buchwalow, I.; Luft, L. C. & Haller, H. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int., 56(5):1737-50, 1999.
13. Kim, J. D.; Kang, S. M.; Seo, B. I.; Choi, H. Y.; Choi, H. S. & Ku, S. K. Anti-diabetic activity of SMK001, a poly herbal formula in streptozotocin-induced diabetic rats: therapeutic study. Biol. Pharm. Bull., 29(3):477-82, 2006.
14. Lee, S. I.; Kim, J. S.; Oh, S. H.; Park, K. Y.; Lee, H. G. & Kim, S. D. Antihyperglycemic effect of Fomitopsis pinicola extracts in streptozotocin-induced diabetic rats. J. Med. Food, 11(3):518-24, 2008.
15. Liu, S. & Barac-Nieto, M. Renal protein degradation in streptozotocin diabetic mice. Diabetes Res. Clin. Pract., 34(3):143-8, 1997.
16. Liu, Y.; Tolbert, E. M. & Dworkin, L. D. In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat. Am. J. Physiol., 271(6):1202-10, 1996.
17. Magee, P. N. & Swann, P. F. Nitroso compounds. Br. Med. Bull., 25:240-44, 1969.
18. Malatiali, S.; Francis, I. & Barac-Nieto, M. Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats. Exp. Diabetes Res., 2008:305403, 2008.
19. Merzouk, H.; Madani, S.; Chabane, Sari, D.; Prost, J.; Bouchenak, M. & Belleville, J. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with Streptozotocin induced diabetes. Clin. Sci. (Lond), 98(1):21-30, 2000.
20. Mozaffari, M. S.; Warren, B. K.; Russell, C. M. & Schaffer, S. W. Renal function in the non-insulin dependent diabetic rat: effect of unilateral nephrectomy. J. Pharmacol. Toxicol, Methods, 37(4):197-203, 1997.
21. New, J. P.; Canavan, J. P.; Flyvbjerg, A.; Hamon, G.; Bilous, R. W. & Marshall, S. M. Renal enlargement and insulinlike growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by Angiotensin converting enzyme inhibition. Diabetologia, 39(2):166-71, 1996.
22. Ohno, T.; Horio, F.; Tanaka, S.; Terada, M.; Namikawa, T. & Kitch, J. Fatty liver and hyperlipidemia in IDDM (insulin dependent diabetes mellitus) of Streptozotocin treated shrews. Life Sci., 66(2):125-31, 2000.
23. Oscika, T. M.; Yu, Y.; Panagiotopoulos, S.; Clavant, S. P.; Kirizis, Z.; Pike, R. N.; Pratt, L. M.; Russo, L. M.; Kemp, B. E.; Camper, W. D. & Jerums, G. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes, 49(1):87-93, 2000.
24. Petlevski, R.; Hadzija, M.; Bajalo, J. L. & Juretic, D. Effects of acarbose on alanine aminotransferase and aspartate aminotransferase activities in the liver of control and diabetic CBA mice. Acta. Pharm., 56(1):87-93, 2006.
25. Piyachaturawat, P.; Poprasit, J.; Glinsukon, T. & Warichanon, C. Gastric mucosal lesions in Streptozotocin-diabetic rats. Cell. Biol. Intern. Rep., 12(1):53-63, 1988.
26. Piyachaturawat, P.; Poprasit, J. & Glinsukon, T. Gastric mucosal secretions and lesions by different doses of Streptozotocin in rats. Toxicol. Lett., 55:21-29, 1991.
27. Punithavathi, V. R.; Anuthama, R. & Prince, P. S. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. J. Appl. Toxicol.; 28(6):806-13, 2008.
28. Ramesh, B. & Pugalendi, K. V. Impact of umbelliferone (7- hydroxycourmarin) on hepatic marker enzymes in Streptozotocin diabetic rats. Indian J. Pharmacol., 38:209-10, 2006.
29. Ren, X. J.; Guan, G. J.; Liu, G.; Zhang, T. & Liu, G. H. Effect of activin A on tubulointerstitial fibrosis in diabetic nephropathy. Nephrology, 14(3):311-20, 2009.
30. Sharma, K. & Ziyadeh, F. N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factorbeta as a key mediator. Diabetes, 44(10):1139-46, 1995.
31. th ed., London, Dawson and Good all, Ltd., 1981, pp 33-53.
32. Wu, K.; Setty, S.; Mauer, S. M.; Killen, P.; Nagase, H.; Michael, A. F. & Tsilibary, E. C. Altered kidney matrix gene expression in early stages of experimental diabetes. Acta. Anat. (Basel), 158(3):155-65, 1997.
33. Zafar, M.; Naeem-ul-Hassan Naqvi, S.; Ahmed, M. & Kaim Khani, Z. A. Altered liver morphology and enzymes in streptozotocin-induced diabetic rats. Int. J. Morphol., 27(3):719-25, 2009a.
34. Zafar, M.; Naeem-ul-Hassan Naqvi, S.; Ahmed, M. & Kaim, Khani, Z. A. Altered kidney morphology and enzymes in streptozotocin-induced diabetic rats. Int. J. Morphol., 27(3):783-90, 2009b.